Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)

Stefan Gluck, Jacques Bonneterre, Aman Buzdar, Jean Marc Nabholtz, John Robertson, Beat Thrlimann, Mikael Von Euler, Tarek Sahmoud, Mark Steinberg, Alan Webster

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)'. Together they form a unique fingerprint.